ImmunOs Therapeutics Announces Poster Presentation at the Society for Immunotherapy of Cancer 36th Annual Meeting (SITC)
ImmunOs Therapeutics AG, a Swiss biotechnology company developing a new class of biologics for the treatment of cancer a…
ImmunOs Therapeutics AG, a Swiss biotechnology company developing a new class of biologics for the treatment of cancer a…
ImmunOs Therapeutics AG, a Swiss biotechnology company developing a new class of biologics for the treatment of cancer a…
MagnetOs U.S. Q1 sales accelerate, rising 117% over Q1 2020 European distribution network expansion ahead of schedul…
– ImmunOs Therapeutics AG, a Swiss bio-technology company developing a new class of biologics for the treatment of cance…
Kuros Biosciences (SIX: KURN) announced today the start of an investigator-led study at University Medical Center (UMC)…
Kuros Biosciences (SIX:KURN) announced today that it has received the CE Mark for MagnetOs Putty indicated for use as an…
Financial highlights CHF 17.0 million cash at year-end CHF 16.9 million equity raise in June 2017 Standby equity facil…
Covagen today announced that the company has secured CHF 42 million in a tranched Series B financing with an option to o…
Dualsystems Biotech and NiKem Research are pleased to announce the formation of a strategic alliance to jointly offer th…
The weekend of 5 to 7 September 2008 Galexis will officially open its new distribution centre in Niederbipp (canton of B…